TGA medicinal cannabis is now a named 2026-27 compliance priority, and new 7 July vaping-device guidance raises scrutiny. What Australian producers and importers should do.
Read MoreCannabis Regulation in Costa Rica: Where the Law Stands
A source-cited guide to Costa Rica cannabis regulation: the medical and hemp verticals under Ley 10.113, the MAG/Salud/ICD licensing split, RTCR 515:2024, and where recreational cannabis stands.
Read MoreGermany’s Proposed Medical Cannabis Crackdown: What a Telemedicine and Mail-Order Ban Would Mean
Germany’s Federal Cabinet backed a draft banning telemedicine prescriptions and mail-order supply of medical cannabis, but the reform stalled after its first reading. Here is what it means for suppliers, especially Canada.
Read MoreBrazil’s Cannabis New Era Begins: ANVISA’s RDC 1,015 Takes Effect and Reshapes Latin America’s Largest Medical Market
Brazil’s medical cannabis industry entered a new chapter on May 4, 2026. After seven years under the provisional framework of RDC 327/2019, ANVISA’s…
Read MoreColombia Medical Cannabis Flower and the Adult-Use Push
Colombia now allows medical cannabis flower in pharmacies and is debating adult-use legalisation. Here is what producers need to know about licences, regulators and export readiness in 2026.
Read MoreThe Global Medical Cannabis Market: From $30.6B in 2025 to $159B by 2033
The global medical cannabis market is no longer a niche sector. As of 2025, more than 50 countries have enacted legal frameworks permitting some form of…
Read More




